Status:
UNKNOWN
Remote Monitoring System for Patients, Who Had Myocardial Infarction
Lead Sponsor:
Ryazan State Medical University
Conditions:
Myocardial Infarction
Adherence, Patient
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
one-centered, open, prospective, non-randomized, controlled clinical study will be aimed at creating remote monitoring system for patients' condition and the development of methodological approaches a...
Detailed Description
The research will involve patients, who had myocardial infraction and who has the high level of potential adherence to treatment, which will be determined by the usage of Russian generic questionnaire...
Eligibility Criteria
Inclusion
- A significant diagnosis of myocardial infraction, confirmed by the level of biomarkers of myocardial necrosis in blood examination (troponin, creatine kinase-MV), electrocardiographic criteria, typical clinical presentation.
- The high level of adherence to treatment
- Signed informed agreement
Exclusion
- Active cancer or remission period less than 5 years;
- Absolute contradictions to the prescription of beta-adrenergic blocking agents, angiotensin converting enzyme inhibitors, statins, antiaggregants.
- Mental illnesses.
- Alcohol and drug abuse
- Patient's noncompliance, according to the researchers
Key Trial Info
Start Date :
October 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04424368
Start Date
October 3 2018
End Date
December 31 2021
Last Update
November 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RyazSMU
Ryazan, Russia